🔗 Share this article

Chancellor Reeves has stated she is preparing "focused steps to deal with cost of living pressures" in next month's financial statement.

In comments to the BBC, she emphasized that reducing inflation is a collective responsibility of both the administration and the Bank of England.

The UK's inflation rate is forecast to be the highest among the G7 industrialized countries this calendar year and the following year.

Potential Energy Cost Measures

Sources suggest the administration could intervene to bring down utility costs, for example by reducing the present 5% rate of value-added tax charged on energy supplies.

A further approach is to reduce some of the government charges currently added to household expenses.

Budgetary Constraints and Analyst Expectations

The government will receive the latest assessment from the independent fiscal watchdog, the OBR, on the start of the week, which will reveal how much space there is for such actions.

The consensus from the majority of experts is that the Chancellor will have to declare tax increases or budget cuts in order to fulfill her voluntary fiscal targets.

Earlier on Thursday, calculations indicated there was a £22 billion deficit for the chancellor to resolve, which is at the more modest range of projections.

"There's a shared task between the Bank of England and the government to further reduce some of the causes of price increases," the Chancellor stated to the BBC in the US capital, at the conferences of the IMF and global financial institution.

Revenue Pledges and Global Concerns

While much of the attention has been on likely tax increases, the Treasury chief said the latest information from the OBR had not altered her commitment to election pledges not to raise tax levels on income tax, VAT or National Insurance.

She blamed an "uncertain world" with increasing international and commercial concerns for the fiscal revenue measures, likely to be targeted on those "most able to pay."

Global Trade Tensions

Addressing worries about the United Kingdom's commercial links with the Asian nation she said: "The UK's national security always come first."

Last week's declaration by China to tighten trade restrictions on critical minerals and other materials that are essential for advanced tech production led American leader Donald Trump to suggest an additional 100% tariff on imports from the Asian country, increasing the possibility of an all-out commercial conflict between the two largest economies.

The American finance chief described China's move "commercial pressure" and "a international production control attempt."

Questioned on considering the US offer to participate in its battle with China, Reeves said she was "very concerned" by Chinese actions and encouraged the Chinese government "not to put up barriers and limit trade."

She said the action was "bad for the global economy and creates additional challenges."

"I believe there are sectors where we must confront Chinese policies, but there are also important prospects to trade with Chinese markets, including financial services and other sectors of the economy. We've got to get that balance appropriate."

The Treasury chief also affirmed she was cooperating with G7 counterparts "on our own critical minerals plan, so that we are more independent."

NHS Medicine Costs and Investment

The Chancellor also acknowledged that the price the NHS spends on pharmaceuticals could increase as a consequence of current negotiations with the Trump administration and its pharmaceutical firms, in return for lower tariffs and investment.

Some of the biggest global drug companies have said in recent statements that they are either delaying or scrapping investments in the United Kingdom, with several attributing the insufficient payments they are receiving.

Last month, the government science advisor said the cost the NHS pays for drugs would have to go up to halt businesses and pharmaceutical investment leaving the UK.

Reeves told the BBC: "It has been observed due to the payment system, that drug testing, recent pharmaceuticals have not been provided in the United Kingdom in the extent that they are in other continental states."

"Our aim is to make sure that individuals getting treatment from the NHS are able to receive the top life-saving treatments in the globe. And so we are looking at this situation, and... seeking to secure more investment into the UK."